Table 3.
Total* | Always ≥90% adherent (n=146) | <90% adherent for ≥1 interval (n=355) | Never ≥90% adherent (n=35)** | ||||
---|---|---|---|---|---|---|---|
N | n | %† | n | %† | n | %† | |
ARV randomization | |||||||
Maternal antiretroviral | 328 | 99 | (30) | 229 | (70) | 23 | (7) |
Infant nevirapine | 173 | 47 | (27) | 126 | (73) | 12 | (7) |
Nutritional randomization | |||||||
No supplement | 230 | 71 | (31) | 159 | (69) | 17 | (7) |
Received supplement | 271 | 75 | (28) | 196 | (72) | 18 | (7) |
Mothers: | |||||||
Age (years) | |||||||
15-25 | 208 | 66 | (32) | 142 | (68) | 18 | (9) |
26-35 | 265 | 78 | (29) | 187 | (71) | 17 | (6) |
36-45 | 27 | 2 | (7) | 25 | (93) | 0 | (0) |
Education | |||||||
Primary school only | 316 | 90 | (28) | 226 | (72) | 19 | (6) |
More than primary school | 184 | 55 | (30) | 129 | (70) | 16 | (9) |
Married | |||||||
No | 35 | 10 | (29) | 25 | (71) | 1 | (3) |
Yes | 466 | 136 | (29) | 330 | (71) | 34 | (7) |
Parity | |||||||
0 | 55 | 22 | (40) | 33 | (60) | 5 | (9) |
≥1 | 445 | 124 | (28) | 321 | (72) | 30 | (7) |
CD4+ count per mm3 | |||||||
200-350 | 162 | 46 | (28) | 116 | (72) | 11 | (7) |
351-500 | 151 | 41 | (27) | 110 | (73) | 11 | (7) |
>500 | 188 | 59 | (31) | 129 | (69) | 13 | (7) |
Plasma viral load copies/mL | |||||||
≤1,000 | 52 | 20 | (38) | 32 | (62) | 1 | (2) |
1,001-10,000 | 135 | 42 | (31) | 93 | (69) | 3 | (2) |
>10,000 | 313 | 83 | (27) | 230 | (73) | 31 | (19) |
Hemoglobin (g/dl) | |||||||
<11 | 262 | 74 | (28) | 188 | (72) | 20 | (8) |
≥11 | 239 | 72 | (30) | 167 | (70) | 15 | (6) |
ARV Regimen‡ | |||||||
Nevirapine based | 9 | 4 | (44) | 5 | (56) | 1 | (11) |
Nelfinavir based | 46 | 13 | (28) | 33 | (72) | 6 | (13) |
Lopinavir/ritonavir based | 273 | 82 | (30) | 191 | (70) | 16 | (6) |
Infants | |||||||
Sex | |||||||
Female | 262 | 67 | (26) | 195 | (74) | 20 | (8) |
Male | 239 | 79 | (33) | 160 | (67) | 15 | (6) |
Birth weight (kg) | |||||||
<2.5 | 36 | 17 | (47) | 19 | (53) | 3 | (8) |
≥2.5 | 465 | 129 | (28) | 336 | (72) | 32 | (7) |
Maternal age, education, parity, and viral load are missing for 1 mother
Columns are not mutually exclusive. Those 'never ≥ 90% adherent' are also included in the '<90% adherent for ≥1 interval' column.
Row percentages are presented
Among those randomized to maternal ARV arm